ID   THRB_RAT                Reviewed;         617 AA.
AC   P18292;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   02-OCT-2024, entry version 182.
DE   RecName: Full=Prothrombin;
DE            EC=3.4.21.5;
DE   AltName: Full=Coagulation factor II;
DE   Contains:
DE     RecName: Full=Activation peptide fragment 1;
DE   Contains:
DE     RecName: Full=Activation peptide fragment 2;
DE   Contains:
DE     RecName: Full=Thrombin light chain;
DE   Contains:
DE     RecName: Full=Thrombin heavy chain;
DE   Flags: Precursor;
GN   Name=F2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=2377469; DOI=10.1093/nar/18.14.4251;
RA   Dihanich M., Monard D.;
RT   "cDNA sequence of rat prothrombin.";
RL   Nucleic Acids Res. 18:4251-4251(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 383-617.
RC   TISSUE=Liver;
RX   PubMed=1557383; DOI=10.1073/pnas.89.7.2779;
RA   Banfield D.K., Macgillivray R.T.;
RT   "Partial characterization of vertebrate prothrombin cDNAs: amplification
RT   and sequence analysis of the B chain of thrombin from nine different
RT   species.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:2779-2783(1992).
RN   [3]
RP   CHARACTERIZATION OF THE TP508 PEPTIDE.
RX   PubMed=1373740; DOI=10.1172/jci115737;
RA   Carney D.H., Mann R., Redin W.R., Pernia S.D., Berry D., Heggers J.P.,
RA   Hayward P.G., Robson M.C., Christie J., Annable C., Fenton W.J. II,
RA   Glenn K.C.;
RT   "Enhancement of incisional wound healing and neovascularization in normal
RT   rats by thrombin and synthetic thrombin receptor-activating peptides.";
RL   J. Clin. Invest. 89:1469-1477(1992).
RN   [4]
RP   CHARACTERIZATION OF THE TP508 PEPTIDE.
RX   PubMed=15885490; DOI=10.1016/j.orthres.2004.10.002;
RA   Wang H., Li X., Tomin E., Doty S.B., Lane J.M., Carney D.H., Ryaby J.T.;
RT   "Thrombin peptide (TP508) promotes fracture repair by up-regulating
RT   inflammatory mediators, early growth factors, and increasing
RT   angiogenesis.";
RL   J. Orthop. Res. 23:671-679(2005).
CC   -!- FUNCTION: Thrombin, which cleaves bonds after Arg and Lys, converts
CC       fibrinogen to fibrin and activates factors V, VII, VIII, XIII, and, in
CC       complex with thrombomodulin, protein C. Functions in blood homeostasis,
CC       inflammation and wound healing. Thrombin triggers the production of
CC       pro-inflammatory cytokines, such as MCP-1/CCL2 and IL8/CXCL8, in
CC       endothelial cells (By similarity). {ECO:0000250|UniProtKB:P00734}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Selective cleavage of Arg-|-Gly bonds in fibrinogen to form
CC         fibrin and release fibrinopeptides A and B.; EC=3.4.21.5;
CC   -!- ACTIVITY REGULATION: Inhibited by SERPINA5. {ECO:0000250}.
CC   -!- SUBUNIT: Heterodimer (named alpha-thrombin) of a light and a heavy
CC       chain; disulfide-linked. Forms a heterodimer with SERPINA5. In plasma,
CC       interacts (via N-terminus) with alpha-1-microglobulin; this interaction
CC       does not prevent the activation of prothrombin to thrombin.
CC       {ECO:0000250|UniProtKB:P00734}.
CC   -!- PTM: The gamma-carboxyglutamyl residues, which bind calcium ions,
CC       result from the carboxylation of glutamyl residues by a microsomal
CC       enzyme, the vitamin K-dependent carboxylase. The modified residues are
CC       necessary for the calcium-dependent interaction with a negatively
CC       charged phospholipid surface, which is essential for the conversion of
CC       prothrombin to thrombin (By similarity). {ECO:0000250}.
CC   -!- PTM: In the penultimate step of the coagulation cascade, prothrombin is
CC       converted to thrombin by the prothrombinase complex composed of factor
CC       Xa (F10), cofactor Va (F5), and phospholipids. This activation requires
CC       factor Xa-catalyzed sequential cleavage at 2 sites, Arg-310 and Arg-
CC       359, along 2 possible pathways. In the first pathway, the first
CC       cleavage occurs at Arg-310, leading to the formation of the inactive
CC       intermediate prethrombin-2. This pathway preferentially occurs on
CC       platelets and in the absence of cofactor Va. In the second pathway, the
CC       first cleavage occurs at Arg-359, which separates protease domain into
CC       2 chains that remain connected through a disulfide bond and generates
CC       the active intermediate meizothrombin. The presence of cofactor Va
CC       directs activation along the meizothrombin pathway and greatly
CC       accelerates the rate of cleavage at Arg-359, but has a smaller effect
CC       on the cleavage of meizothrombin at Arg-310. Meizothrombin accumulates
CC       as an intermediate when prothrombinase is assembled on the membrane of
CC       red blood cells. {ECO:0000250|UniProtKB:P00734}.
CC   -!- MISCELLANEOUS: Thrombin can itself cleave the N-terminal fragment
CC       (fragment 1) of the prothrombin, prior to its activation by factor Xa.
CC   -!- MISCELLANEOUS: The peptide TP508 is able to accelerate repair of both
CC       soft and hard tissues.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00274}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X52835; CAA37017.1; -; Transcribed_RNA.
DR   EMBL; M81397; AAA42240.1; -; mRNA.
DR   PIR; S10511; S10511.
DR   AlphaFoldDB; P18292; -.
DR   SMR; P18292; -.
DR   STRING; 10116.ENSRNOP00000022233; -.
DR   BindingDB; P18292; -.
DR   ChEMBL; CHEMBL3078; -.
DR   MEROPS; S01.217; -.
DR   GlyCosmos; P18292; 4 sites, No reported glycans.
DR   GlyGen; P18292; 4 sites.
DR   iPTMnet; P18292; -.
DR   PhosphoSitePlus; P18292; -.
DR   jPOST; P18292; -.
DR   PaxDb; 10116-ENSRNOP00000022233; -.
DR   Ensembl; ENSRNOT00055027272; ENSRNOP00055021932; ENSRNOG00055016064.
DR   Ensembl; ENSRNOT00060016781; ENSRNOP00060013123; ENSRNOG00060009925.
DR   Ensembl; ENSRNOT00065040604; ENSRNOP00065033093; ENSRNOG00065023700.
DR   UCSC; RGD:61996; rat.
DR   AGR; RGD:61996; -.
DR   RGD; 61996; F2.
DR   eggNOG; ENOG502QTSX; Eukaryota.
DR   InParanoid; P18292; -.
DR   PhylomeDB; P18292; -.
DR   Reactome; R-RNO-140837; Intrinsic Pathway of Fibrin Clot Formation.
DR   Reactome; R-RNO-140875; Common Pathway of Fibrin Clot Formation.
DR   Reactome; R-RNO-159740; Gamma-carboxylation of protein precursors.
DR   Reactome; R-RNO-159763; Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus.
DR   Reactome; R-RNO-159782; Removal of aminoterminal propeptides from gamma-carboxylated proteins.
DR   Reactome; R-RNO-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-RNO-375276; Peptide ligand-binding receptors.
DR   Reactome; R-RNO-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-RNO-416476; G alpha (q) signalling events.
DR   Reactome; R-RNO-456926; Thrombin signalling through proteinase activated receptors (PARs).
DR   Reactome; R-RNO-76009; Platelet Aggregation (Plug Formation).
DR   Reactome; R-RNO-977606; Regulation of Complement cascade.
DR   PRO; PR:P18292; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IDA:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004175; F:endopeptidase activity; ISO:RGD.
DR   GO; GO:0008201; F:heparin binding; ISO:RGD.
DR   GO; GO:0001530; F:lipopolysaccharide binding; ISO:RGD.
DR   GO; GO:0008233; F:peptidase activity; ISO:RGD.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; ISO:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:RGD.
DR   GO; GO:0070053; F:thrombospondin receptor activity; ISO:RGD.
DR   GO; GO:0006953; P:acute-phase response; IEA:UniProtKB-KW.
DR   GO; GO:0061844; P:antimicrobial humoral immune response mediated by antimicrobial peptide; ISO:RGD.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; ISO:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0042730; P:fibrinolysis; ISO:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:1990806; P:ligand-gated ion channel signaling pathway; ISO:RGD.
DR   GO; GO:0048712; P:negative regulation of astrocyte differentiation; ISO:RGD.
DR   GO; GO:1900016; P:negative regulation of cytokine production involved in inflammatory response; ISO:RGD.
DR   GO; GO:0045861; P:negative regulation of proteolysis; ISO:RGD.
DR   GO; GO:0030168; P:platelet activation; ISO:RGD.
DR   GO; GO:0030194; P:positive regulation of blood coagulation; IMP:RGD.
DR   GO; GO:0030307; P:positive regulation of cell growth; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0032967; P:positive regulation of collagen biosynthetic process; ISO:RGD.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; ISO:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:1900738; P:positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:1900182; P:positive regulation of protein localization to nucleus; ISO:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:2000379; P:positive regulation of reactive oxygen species metabolic process; ISO:RGD.
DR   GO; GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; ISO:RGD.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0008360; P:regulation of cell shape; ISO:RGD.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0014854; P:response to inactivity; IEP:RGD.
DR   GO; GO:1904016; P:response to Thyroglobulin triiodothyronine; IEP:RGD.
DR   GO; GO:1905225; P:response to thyrotropin-releasing hormone; IEP:RGD.
DR   GO; GO:0097068; P:response to thyroxine; IEP:RGD.
DR   GO; GO:0009611; P:response to wounding; ISO:RGD.
DR   CDD; cd00108; KR; 2.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   Gene3D; 2.40.20.10; Plasminogen Kringle 4; 2.
DR   Gene3D; 4.10.140.10; Thrombin light chain domain; 1.
DR   Gene3D; 2.40.10.10; Trypsin-like serine proteases; 2.
DR   InterPro; IPR035972; GLA-like_dom_SF.
DR   InterPro; IPR000294; GLA_domain.
DR   InterPro; IPR000001; Kringle.
DR   InterPro; IPR013806; Kringle-like.
DR   InterPro; IPR018056; Kringle_CS.
DR   InterPro; IPR038178; Kringle_sf.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR043504; Peptidase_S1_PA_chymotrypsin.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR003966; Prothrombin/thrombin.
DR   InterPro; IPR051659; Serine_Protease_S1-Domain.
DR   InterPro; IPR018992; Thrombin_light_chain.
DR   InterPro; IPR037111; Thrombin_light_chain_sf.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR018114; TRYPSIN_HIS.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   PANTHER; PTHR24254; PROTHROMBIN; 1.
DR   PANTHER; PTHR24254:SF10; PROTHROMBIN; 1.
DR   Pfam; PF00594; Gla; 1.
DR   Pfam; PF00051; Kringle; 2.
DR   Pfam; PF09396; Thrombin_light; 1.
DR   Pfam; PF00089; Trypsin; 1.
DR   PIRSF; PIRSF001149; Thrombin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   PRINTS; PR00001; GLABLOOD.
DR   PRINTS; PR00018; KRINGLE.
DR   PRINTS; PR01505; PROTHROMBIN.
DR   SMART; SM00069; GLA; 1.
DR   SMART; SM00130; KR; 2.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF57630; GLA-domain; 1.
DR   SUPFAM; SSF57440; Kringle-like; 2.
DR   SUPFAM; SSF50494; Trypsin-like serine proteases; 1.
DR   PROSITE; PS00011; GLA_1; 1.
DR   PROSITE; PS50998; GLA_2; 1.
DR   PROSITE; PS00021; KRINGLE_1; 2.
DR   PROSITE; PS50070; KRINGLE_2; 2.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   1: Evidence at protein level;
KW   Acute phase; Blood coagulation; Calcium;
KW   Cleavage on pair of basic residues; Disulfide bond;
KW   Gamma-carboxyglutamic acid; Glycoprotein; Hemostasis; Hydrolase; Kringle;
KW   Protease; Reference proteome; Repeat; Serine protease; Signal; Zymogen.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000255"
FT   PROPEP          25..43
FT                   /id="PRO_0000028177"
FT   CHAIN           44..617
FT                   /note="Prothrombin"
FT                   /id="PRO_0000028178"
FT   PEPTIDE         44..200
FT                   /note="Activation peptide fragment 1"
FT                   /id="PRO_0000028179"
FT   PEPTIDE         201..323
FT                   /note="Activation peptide fragment 2"
FT                   /id="PRO_0000028180"
FT   CHAIN           311..359
FT                   /note="Thrombin light chain"
FT                   /id="PRO_0000028181"
FT   CHAIN           360..617
FT                   /note="Thrombin heavy chain"
FT                   /id="PRO_0000028182"
FT   DOMAIN          44..90
FT                   /note="Gla"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00463"
FT   DOMAIN          109..187
FT                   /note="Kringle 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00121"
FT   DOMAIN          215..292
FT                   /note="Kringle 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00121"
FT   DOMAIN          360..614
FT                   /note="Peptidase S1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00274"
FT   REGION          547..569
FT                   /note="High affinity receptor-binding region which is also
FT                   known as the TP508 peptide"
FT   ACT_SITE        402
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        458
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        564
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250"
FT   SITE            200..201
FT                   /note="Cleavage; by thrombin"
FT   SITE            310..311
FT                   /note="Cleavage; by factor Xa"
FT                   /evidence="ECO:0000250|UniProtKB:P00734"
FT   SITE            359..360
FT                   /note="Cleavage; by factor Xa"
FT                   /evidence="ECO:0000250|UniProtKB:P00734"
FT   MOD_RES         50
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P00735,
FT                   ECO:0000255|PROSITE-ProRule:PRU00463"
FT   MOD_RES         51
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P00735,
FT                   ECO:0000255|PROSITE-ProRule:PRU00463"
FT   MOD_RES         58
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P00735,
FT                   ECO:0000255|PROSITE-ProRule:PRU00463"
FT   MOD_RES         60
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P00735,
FT                   ECO:0000255|PROSITE-ProRule:PRU00463"
FT   MOD_RES         63
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P00735,
FT                   ECO:0000255|PROSITE-ProRule:PRU00463"
FT   MOD_RES         64
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P00735,
FT                   ECO:0000255|PROSITE-ProRule:PRU00463"
FT   MOD_RES         69
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P00735,
FT                   ECO:0000255|PROSITE-ProRule:PRU00463"
FT   MOD_RES         70
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P00735,
FT                   ECO:0000255|PROSITE-ProRule:PRU00463"
FT   MOD_RES         73
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P00735,
FT                   ECO:0000255|PROSITE-ProRule:PRU00463"
FT   MOD_RES         76
FT                   /note="4-carboxyglutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P00735,
FT                   ECO:0000255|PROSITE-ProRule:PRU00463"
FT   CARBOHYD        120
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        144
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        412
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        552
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        61..66
FT                   /evidence="ECO:0000250"
FT   DISULFID        91..104
FT                   /evidence="ECO:0000250"
FT   DISULFID        109..187
FT                   /evidence="ECO:0000250"
FT   DISULFID        130..170
FT                   /evidence="ECO:0000250"
FT   DISULFID        158..182
FT                   /evidence="ECO:0000250"
FT   DISULFID        215..292
FT                   /evidence="ECO:0000250"
FT   DISULFID        236..276
FT                   /evidence="ECO:0000250"
FT   DISULFID        264..287
FT                   /evidence="ECO:0000250"
FT   DISULFID        332..478
FT                   /note="Interchain (between light and heavy chains)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00121,
FT                   ECO:0000255|PROSITE-ProRule:PRU00274, ECO:0000255|PROSITE-
FT                   ProRule:PRU00463"
FT   DISULFID        387..403
FT                   /evidence="ECO:0000250"
FT   DISULFID        532..546
FT                   /evidence="ECO:0000250"
FT   DISULFID        560..590
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   617 AA;  70412 MW;  AD27D1B71445DB1D CRC64;
     MLHVRGLGLP GCLALAALAS LVHSQHVFLA PQQALSLLQR VRRANSGFLE ELRKGNLERE
     CVEEQCSYEE AFEALESPQD TDVFWAKYTV CDSVRKPRET FMDCLEGRCA MDLGLNYHGN
     VSVTHTGIEC QLWRSRYPHR PDINSTTHPG ADLKENFCRN PDSSTSGPWC YTTDPTVRRE
     ECSIPVCGQE GRTTVKMTPR SRGSKENLSP PLGECLLERG RLYQGNLAVT TLGSPCLAWD
     SLPTKTLSKY QNFDPEVKLV QNFCRNPDRD EEGAWCFVAQ QPGFEYCSLN YCDEAVGEEN
     HDGDESIAGR TTDAEFHTFF DERTFGLGEA DCGLRPLFEK KSLTDKTEKE LLDSYIDGRI
     VEGWDAEKGI APWQVMLFRK SPQELLCGAS LISDRWVLTA AHCILYPPWD KNFTENDLLV
     RIGKHSRTRY ERNVEKISML EKIYIHPRYN WRENLDRDIA LLKLKKPVPF SDYIHPVCLP
     DKQTVTSLLQ AGYKGRVTGW GNLRETWTTN INEIQPSVLQ VVNLPIVERP VCKASTRIRI
     TDNMFCAGFK VNDTKRGDAC EGDSGGPFVM KSPYNHRWYQ MGIVSWGEGC DRNGKYGFYT
     HVFRLKRWMQ KVIDQHR
//
